Skip to main content
AYTU logo

AYTU · Aytu Biopharma, Inc · Analyst Estimates

Track AYTU — free
$1.93 +0.03 (+1.58%) At close · Oct 26
Market Cap
$20.97M
Shares
10.87M
Volume · Oct 26 16.56K Avg daily vol (3M) 34.93K

Analyst Estimates

Compare analyst forecasts for Aytu Biopharma, Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-14 18:11 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2027-06-30

Analyst estimates for FY ending 2027-06-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.57
-0.37
-0.16
2
-0.075
-0.075
-0.075
-0.075
0
2
0
0
Revenue
USD
Publication date not stated
67.43M
67.91M
68.30M
3
— — — — — — — —

FY ending 2028-06-30

Analyst estimates for FY ending 2028-06-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.14
0.16
0.17
2
0.00
0.00
0.00
0.00
0
0
0
0
Revenue
USD
Publication date not stated
76.00M
86.91M
94.10M
3
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.26
-0.18
-0.10
2
-0.02
-0.02
-0.02
-0.02
0
1
0
0
Revenue
USD
Publication date not stated
12.30M
13.27M
14.50M
3
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.18
-0.14
-0.09
2
0.02
0.02
0.02
0.02
0
1
0
0
Revenue
USD
Publication date not stated
15.00M
15.28M
15.70M
3
— — — — — — — —
Key facts CIK 1385818 CUSIP 054754858 13F (30d) 4 filings 4 filers Visit website Investor relations